Inogen (INGN) Total Non-Current Liabilities (2013 - 2026)
Inogen (INGN) reported Total Non-Current Liabilities of $84.6 million for Q1 2026, down 23.38% year-over-year from $110.5 million in Q1 2025, and down 4.05% on a QoQ basis from $88.2 million in Q4 2025.
Inogen (INGN) has 14 years of Total Non-Current Liabilities data on file, last reported at $84.6 million in Q1 2026.
- Quarterly Total Non-Current Liabilities fell 23.38% year-over-year to $84.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $84.6 million (down 23.38% YoY) and the FY2025 annual result came in at $88.2 million, down 19.32% from the prior year.
- Total Non-Current Liabilities fell to $84.6 million in Q1 2026 per INGN's latest filing, from $88.2 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $113.1 million in Q1 2024 and bottomed at $84.6 million in Q1 2026.
- The 5-year median for Total Non-Current Liabilities is $108.9 million (2024), against an average of $102.1 million.
- The widest annual swing landed in 2024, when Total Non-Current Liabilities gained 26.64%; it then retreated 23.38% in 2026.
- Tracing INGN's Total Non-Current Liabilities over 5 years: stood at $95.5 million in 2022, then advanced by 16.62% to $111.4 million in 2023, then retreated by 1.85% to $109.3 million in 2024, then retreated by 19.32% to $88.2 million in 2025, then dropped by 4.05% to $84.6 million in 2026.
- Per Business Quant, the three latest INGN Total Non-Current Liabilities figures stand at $84.6 million (Q1 2026), $88.2 million (Q4 2025), and $92.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 40.52 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 15.78 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 2.44 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 9.85 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 3.53 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 3.47 Bn |
| 10 | Inogen | 165.85 Mn | 71.44 Mn | 37.86 Mn | 84.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 84.63 Mn |
| Dec 31, 2025 | 88.20 Mn |
| Sep 30, 2025 | 92.02 Mn |
| Jun 30, 2025 | 95.56 Mn |
| Mar 31, 2025 | 110.46 Mn |
| Dec 31, 2024 | 109.33 Mn |
| Sep 30, 2024 | 108.94 Mn |
| Jun 30, 2024 | 110.14 Mn |
| Mar 31, 2024 | 113.13 Mn |
| Dec 31, 2023 | 111.38 Mn |
| Sep 30, 2023 | 109.89 Mn |
| Jun 30, 2023 | 86.98 Mn |
| Mar 31, 2023 | 92.36 Mn |
| Dec 31, 2022 | 95.51 Mn |
| Sep 30, 2022 | 111.11 Mn |
| Jun 30, 2022 | 106.39 Mn |
| Mar 31, 2022 | 109.76 Mn |
| Dec 31, 2021 | 112.04 Mn |
| Sep 30, 2021 | 113.33 Mn |
| Jun 30, 2021 | 118.13 Mn |
| Mar 31, 2021 | 110.98 Mn |
| Dec 31, 2020 | 103.58 Mn |
| Sep 30, 2020 | 99.79 Mn |
| Mar 31, 2020 | 103.86 Mn |
| Dec 31, 2019 | 95.07 Mn |
| Sep 30, 2019 | 94.42 Mn |
| Jun 30, 2019 | 63.69 Mn |
| Mar 31, 2019 | 60.28 Mn |
| Dec 31, 2018 | 64.64 Mn |
| Sep 30, 2018 | 64.95 Mn |
| Jun 30, 2018 | 60.22 Mn |
| Mar 31, 2018 | 52.83 Mn |
| Dec 31, 2017 | 44.37 Mn |
| Sep 30, 2017 | 45.29 Mn |
| Jun 30, 2017 | 43.21 Mn |
| Mar 31, 2017 | 34.59 Mn |
| Dec 31, 2016 | 31.68 Mn |
| Sep 30, 2016 | 36.87 Mn |
| Jun 30, 2016 | 34.94 Mn |
| Mar 31, 2016 | 29.89 Mn |
| Dec 31, 2015 | 26.55 Mn |
| Sep 30, 2015 | 26.93 Mn |
| Jun 30, 2015 | 28.74 Mn |
| Mar 31, 2015 | 25.43 Mn |
| Dec 31, 2014 | 21.56 Mn |
| Sep 30, 2014 | 22.74 Mn |
| Jun 30, 2014 | 34.18 Mn |
| Mar 31, 2014 | 27.17 Mn |
| Dec 31, 2013 | 25.64 Mn |